(Z)-4-ethyl-N-(oxazolidin-2-ylidene)aniline

ID: ALA2286072

Cas Number: 101831-54-3

PubChem CID: 58911

Max Phase: Preclinical

Molecular Formula: C11H14N2O

Molecular Weight: 190.25

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1ccc(/N=C2/NCCO2)cc1

Standard InChI:  InChI=1S/C11H14N2O/c1-2-9-3-5-10(6-4-9)13-11-12-7-8-14-11/h3-6H,2,7-8H2,1H3,(H,12,13)

Standard InChI Key:  LKGCFZRHTPSNTD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
   17.5093   -1.4796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8801   -2.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6966   -2.2537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1433   -1.5669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7675   -0.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9522   -0.7954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9594   -1.6086    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.3313   -2.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9618   -3.0644    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.5403   -3.6415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2681   -3.2695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1391   -2.4626    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6932   -1.4368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3223   -0.7087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  1 13  1  0
 13 14  1  0
M  END

Alternative Forms

Associated Targets(non-human)

oa1 Octopamine receptor (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 190.25Molecular Weight (Monoisotopic): 190.1106AlogP: 1.86#Rotatable Bonds: 2
Polar Surface Area: 33.62Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.02CX LogP: 2.74CX LogD: 2.05
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.77Np Likeness Score: -0.72

References

1. HIRASHIMA A, PAN C, KATAFUCHI Y, TANIGUCHI E, ETO M.  (1996)  Synthesis and Octopaminergic-Agonist Activity of 2-(Arylimino)oxazolidines and 2-(Substituted Benzylamino)-2-oxazolines,  21  (4): [10.1584/jpestics.21.419]

Source